In the sensitivity analyses, the primary outcome analysis was repeated for the PP sample, defined as participants who followed the study protocol with full adherence, attending all study visits with no substantial interruptions in treatment as monitored from the drug dose diary
Anti-inflammatory Mechanisms BPC-157 has been studied in models of inflammation, with research suggesting modulation of inflammatory cytokine activity
These are early signs that the medication is reaching therapeutic levels through consistent sublingual absorption
Andreeff M , Kojima K, Padmanabhan S, Strair R, Kirschbaum M, Maslak P, Hillmen P, O'Brien S, Samaniego F, Borthakur G, Konopleva M, Vassilev L, Nichols G
May cause minor lifestyle adjustments